Review of INTREPID Phase II Clinical Study

Show Description +

Peter Kaiser, MD, provides an update on the results of the INTREPID Phase II clinical study on the Oraya radiation device.

Posted: 3/25/2013

Up Next

Name: Review of INTREPID Phase II Clinical Study
Uploaded: 2013-03-25T14:39:00+00:00
Description: Peter Kaiser, MD, provides an update on the results of the INTREPID Phase II clinical study on the Oraya radiation device.

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

Stanislao Rizzo, MD

Pinhole Effect in Double Peel for Macular Hole

Hudson de Carvalho Nakamura, MD

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Frederic Aissani, MD

Macular Hole Surgery: Retinal Massager

Manish Nagpal, MS, DO, FRCS(UK)

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Frederic Aissani, MD

The Big Mac: ILM Technique for Large Macular Holes

Hudson Nakamura, MD

ILM Peel for Macular Hole Under Liquid PFC

Hudson Nakamura, MD

My Peeling Technique for a Dense Plaque on the Posterior Capsule

Ashraf Armia, FRCSG, FACS

Experience a New Dimension: How Eyetube3D Works!

25-Gauge Vitrectomy for Retained Lens Fragments

Yoreh Barak, MD, Lana Rifkin, MD, Omar Saleh, MD, Shlomit Schaal, MD, PhD

Review of INTREPID Phase II Clinical Study

Peter Kaiser, MD

Peter Kaiser, MD, provides an update on the results of the INTREPID Phase II clinical study on the Oraya radiation device.

Posted: 3/25/2013

Please log in to leave a comment.

More in Retina

Observation vs. Vitrectomy for Floaters

Kyle Kovacs, MD; Matthew Starr, MD; and Neda Valikodath, MD

IL-6 Inhibition in Diabetic Macular Edema

Arshad M. Khanani, MD, MA, FASRS, and Roger A. Goldberg, MD

Phase 3 Clinical Trial Results for OTX-TKI

Patricio G. Schlottmann, MD

Using OCT and AI to Evaluate Uveitis

Parisa Emami-Naeini, MD, MPH